| 000 | 01575 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517074200.0 | ||
| 264 | 0 | _c20170106 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep19579 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFan, Ching-Hsiang | |
| 245 | 0 | 0 |
_aNoninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease. _h[electronic resource] |
| 260 |
_bScientific reports _cJan 2016 |
||
| 300 |
_a19579 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aGlial Cell Line-Derived Neurotrophic Factor _xgenetics |
| 650 | 0 | 4 | _aMicrobubbles |
| 650 | 0 | 4 | _aMotor Activity |
| 650 | 0 | 4 |
_aParkinson Disease _xgenetics |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPlasmids _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aUltrasonic Waves |
| 700 | 1 | _aTing, Chien-Yu | |
| 700 | 1 | _aLin, Chung-Yin | |
| 700 | 1 | _aChan, Hong-Lin | |
| 700 | 1 | _aChang, Yuan-Chih | |
| 700 | 1 | _aChen, You-Yin | |
| 700 | 1 | _aLiu, Hao-Li | |
| 700 | 1 | _aYeh, Chih-Kuang | |
| 773 | 0 |
_tScientific reports _gvol. 6 _gp. 19579 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep19579 _zAvailable from publisher's website |
| 999 |
_c25647596 _d25647596 |
||